← Back to Search

Arm A ("Knowing your Options", "Prostate Choice") for Prostate Cancer

Phase 3
Waitlist Available
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This randomized phase III trial studies how well decision aids work in improving knowledge in patients with newly diagnosed prostate cancer. Decision aids may improve patients' knowledge of their condition and options for treatment, and may also help when talking with their doctor.

Eligible Conditions
  • Prostate Cancer
  • Low PSA Level
  • Prostate-Specific Antigen

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Knowledge Assessed by Prostate Cancer Treatment Questionnaire
Secondary study objectives
Clinical Time Required
Decisional Quality as Measured by Decisional Conflict Scale Decisional Regret
Quality of Life Assessed by Questionnaire
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Arm C ("Prostate Choice")Experimental Treatment5 Interventions
Patients receive "Prostate Choice" decision aid during their consultation visit.
Group II: Arm B ("Knowing your Options")Experimental Treatment5 Interventions
Patients receive "Knowing your Options" decision aid before their consultation visit.
Group III: Arm A ("Knowing your Options", "Prostate Choice")Experimental Treatment5 Interventions
Patients receive decision aids "Knowing your Options" before and "Prostate Choice" during their consultation visit.
Group IV: Arm D (usual care)Active Control5 Interventions
Patients undergo usual care.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,842 Total Patients Enrolled
567 Trials studying Prostate Cancer
529,809 Patients Enrolled for Prostate Cancer
Alliance for Clinical Trials in OncologyLead Sponsor
512 Previous Clinical Trials
217,314 Total Patients Enrolled
30 Trials studying Prostate Cancer
5,924 Patients Enrolled for Prostate Cancer
tilburt.jon@mayo.edu tilburt.jon@mayo.edu, MDStudy ChairMayo Clinic
~19 spots leftby Sep 2025